{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T03:31:02Z","timestamp":1772681462033,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:00:00Z","timestamp":1720656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>A 36-year-old unmarried male chef was incidentally diagnosed with hypokalemia during an evaluation for an acute perianal abscess. Despite potassium supplementation, he developed progressive weakness in his lower limbs, culminating in an inability to stand. Investigations confirmed severe hypokalemia, metabolic alkalosis, hypomagnesemia, secondary hyperaldosteronism, and low urinary calcium excretion, with normotension. The patient\u2019s long-standing stunted growth and lean physique since childhood were noted. Biochemical assays further identified type 2 diabetes mellitus and metabolic syndrome. Genetic analysis revealed three heterozygous <jats:italic>SLC12A3<\/jats:italic> mutations (M1: c.421G&amp;gt;A: <jats:italic>p<\/jats:italic>.G141R, M2: c.509T&amp;gt;A:<jats:italic>p<\/jats:italic>.L170Q, and M3: c.704C&amp;gt;A: <jats:italic>p<\/jats:italic>.T235K), compound heterozygo us and derived from both parents, with M1 and M3 reported here for the first time. Treatment with spironolactone and oral potassium chloride stabilized his potassium levels. Following the administration of SGLT2 inhibitors in patients receiving hypoglycemic therapy, we observed a mild decrease in serum sodium levels. This case highlights the criticality of vigilant metabolic surveillance in Gitelman syndrome and advises prudence with SGLT2 inhibitors in those with concurrent type 2 diabetes, given the risk of potentially aggravate sodium loss.<\/jats:p>","DOI":"10.3389\/fgene.2024.1391015","type":"journal-article","created":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:52:38Z","timestamp":1720673558000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report: Two novel compound heterozygous variant of SLC12A3 gene in a gitelman syndrome family and literature review"],"prefix":"10.3389","volume":"15","author":[{"given":"Xiaochen","family":"Ji","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lichao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e19169","DOI":"10.7759\/cureus.19169","article-title":"Euglycemic diabetic ketoacidosis due to SGLT2 inhibitor in a patient with gitelman syndrome: a therapeutic dilemma","volume":"13","author":"Ahmed","year":"2021","journal-title":"Cureus"},{"key":"B2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.kint.2016.09.046","article-title":"Gitelman syndrome: consensus and guidance from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"91","author":"Blanchard","year":"2017","journal-title":"Kidney Int."},{"key":"B3","doi-asserted-by":"publisher","first-page":"C601","DOI":"10.1152\/ajpcell.00070.2011","article-title":"Similar effects of all WNK3 variants on SLC12 cotransporters","volume":"301","author":"Cruz-Rangel","year":"2011","journal-title":"Am. J. physiology. Cell physiology"},{"key":"B4","doi-asserted-by":"publisher","first-page":"F733","DOI":"10.1152\/ajprenal.00232.2023","article-title":"Angiotensin II hypertension along the female rat tubule: predicted impact on coupled transport of Na+ and K","volume":"325","author":"Edwards","year":"2023","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/s41586-023-05718-0","article-title":"Structure and thiazide inhibition mechanism of the human Na-Cl cotransporter","volume":"614","author":"Fan","year":"2023","journal-title":"Nature"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2984","DOI":"10.1093\/eurheartj\/ehac306","article-title":"Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled","volume":"43","author":"Ferreira","year":"2022","journal-title":"Eur. Heart J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ejhg.2011.189","article-title":"Novel NCC mutants and functional analysis in a new cohort of patients with Gitelman syndrome","volume":"20","author":"Glaudemans","year":"2012","journal-title":"Eur. J. Hum. Genet. EJHG."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1007\/s11606-020-05731-3","article-title":"Thiazide diuretic-induced change in fasting plasma glucose: a meta-analysis of randomized clinical trials","volume":"35","author":"Hall","year":"2020","journal-title":"J. general Intern. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1093\/ndt\/gfn619","article-title":"Heterozygous mutations of the sodium chloride cotransporter in Chinese children: prevalence and association with blood pressure","volume":"24","author":"Hsu","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"B10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.diabet.2019.10.002","article-title":"Insulin secretion and sensitivity before and after surgical treatment for aldosterone-producing adenoma","volume":"46","author":"Komada","year":"2020","journal-title":"Diabetes Metab."},{"key":"B11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12920-021-01047-1","article-title":"A novel compound heterozygous variant of the SLC12A3 gene in Gitelman syndrome with diabetes and the choices of the appropriate hypoglycemic drugs: a case report","volume":"14","author":"Liu","year":"2021","journal-title":"BMC Med. Genomics"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1007\/s00125-018-4616-0","article-title":"Correction to: epidemiology of diabetes and diabetic complications in China","volume":"61","author":"Ma","year":"2018","journal-title":"Diabetologia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"eadd7176","DOI":"10.1126\/sciadv.add7176","article-title":"Cryo-EM structure of the human sodium-chloride cotransporter NCC","volume":"8","author":"Nan","year":"2022","journal-title":"Sci. Adv."},{"key":"B14","doi-asserted-by":"publisher","first-page":"e030578","DOI":"10.1161\/JAHA.123.030578","article-title":"Sodium-glucose cotransporter-2 inhibitors and primary prevention of atherosclerotic cardiovascular disease: a meta-analysis of randomized trials and systematic review","volume":"12","author":"Rahman","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"B15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.coph.2020.06.001","article-title":"Evolving understanding of cardiovascular protection by SGLT2 inhibitors: focus on renal protection, myocardial effects, uric acid, and magnesium balance","volume":"54","author":"Ray","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1242\/jcs.025312","article-title":"Activation of the thiazide-sensitive Na+-Cl-cotransporter by the WNK-regulated kinases SPAK and OSR1","volume":"121","author":"Richardson","year":"2008","journal-title":"J. Cell Sci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.clnu.2013.07.010","article-title":"Serum potassium level is associated with metabolic syndrome: a population-based study","volume":"33","author":"Sun","year":"2014","journal-title":"Clin. Nutr. Edinb. Scotl."},{"key":"B18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1291\/hypres.27.327","article-title":"A high prevalence of Gitelman's syndrome mutations in Japanese","volume":"27","author":"Tago","year":"2004","journal-title":"Hypertens. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1681\/asn.2021050596","article-title":"Gitelman-like syndrome caused by pathogenic variants in mtDNA","volume":"33","author":"Viering","year":"2022","journal-title":"J. Am. Soc. Nephrol. JASN"},{"key":"B20","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/nm.3890","article-title":"Interleukin 18 function in atherosclerosis is mediated by the interleukin 18 receptor and the Na-Cl co-transporter","volume":"21","author":"Wang","year":"2015","journal-title":"Nat. Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"C1512","DOI":"10.1152\/ajpcell.00272.2021","article-title":"Interleukin 6 mediated activation of the mineralocorticoid receptor in the aldosterone-sensitive distal nephron","volume":"323","author":"Wynne","year":"2022","journal-title":"Am. J. physiology. Cell physiology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"Prevalence and control of diabetes in Chinese adults","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"key":"B23","doi-asserted-by":"publisher","first-page":"e33959","DOI":"10.1097\/MD.0000000000033959","article-title":"Case report: gitelman syndrome with diabetes: confirmed by both hydrochlorothiazide test and genetic testing","volume":"102","author":"Yang","year":"2023","journal-title":"Med. Baltim."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1327729","DOI":"10.3389\/fendo.2023.1327729","article-title":"The first compound heterozygous mutations in SLC12A3 and PDX1 genes: a unique presentation of Gitelman syndrome with distinct insulin resistance and familial diabetes insights","volume":"14","author":"Yin","year":"2023","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B25","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1530\/EC-17-0014","article-title":"Glucose tolerance and insulin responsiveness in Gitelman syndrome patients","volume":"6","author":"Yuan","year":"2017","journal-title":"Endocr. Connect."},{"key":"B26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/s41371-018-0036-3","article-title":"Impact of long-term potassium supplementation on thiazide diuretic-induced abnormalities of glucose and uric acid metabolisms","volume":"32","author":"Zhang","year":"2018","journal-title":"J. Hum. Hypertens."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1391015\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T04:52:42Z","timestamp":1720673562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2024.1391015\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,11]]},"references-count":27,"alternative-id":["10.3389\/fgene.2024.1391015"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2024.1391015","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,11]]},"article-number":"1391015"}}